Report Detail
Global Therapeutic Nuclear Medicines Market Growth 2019-2024
- RnM3391506 |
- 07 May, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Other
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.
According to this study, over the next five years the Therapeutic Nuclear Medicines market will register a 18.7% CAGR in terms of revenue, the global market size will reach US$ 1968.7 million by 2024, from US$ 836.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Nuclear Medicines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.
This study considers the Therapeutic Nuclear Medicines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thyroid
Bone Metastasis
Lymphoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Therapeutic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
Focuses on the key global Therapeutic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Therapeutic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Therapeutic Nuclear Medicines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Therapeutic Nuclear Medicines Consumption 2014-2024
- 2.1.2 Therapeutic Nuclear Medicines Consumption CAGR by Region
- 2.2 Therapeutic Nuclear Medicines Segment by Type
- 2.2.1 Radium-223
- 2.2.2 Lutetium-177
- 2.2.3 Iodine-131
- 2.2.4 Other
- 2.3 Therapeutic Nuclear Medicines Consumption by Type
- 2.3.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2014-2019)
- 2.4 Therapeutic Nuclear Medicines Segment by Application
- 2.4.1 Thyroid
- 2.4.2 Bone Metastasis
- 2.4.3 Lymphoma
- 2.4.4 Other
- 2.5 Therapeutic Nuclear Medicines Consumption by Application
- 2.5.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Therapeutic Nuclear Medicines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Application (2014-2019)
3 Global Therapeutic Nuclear Medicines by Manufacturers
- 3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers
- 3.1.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2019)
- 3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2019)
- 3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers
- 3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2019)
- 3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2019)
- 3.3 Global Therapeutic Nuclear Medicines Sale Price by Manufacturers
- 3.4 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
- 3.4.1 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Manufacturers
- 3.4.2 Players Therapeutic Nuclear Medicines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Therapeutic Nuclear Medicines by Regions
- 4.1 Therapeutic Nuclear Medicines by Regions
- 4.1.1 Global Therapeutic Nuclear Medicines Consumption by Regions
- 4.1.2 Global Therapeutic Nuclear Medicines Value by Regions
- 4.2 Americas Therapeutic Nuclear Medicines Consumption Growth
- 4.3 APAC Therapeutic Nuclear Medicines Consumption Growth
- 4.4 Europe Therapeutic Nuclear Medicines Consumption Growth
- 4.5 Middle East & Africa Therapeutic Nuclear Medicines Consumption Growth
5 Americas
- 5.1 Americas Therapeutic Nuclear Medicines Consumption by Countries
- 5.1.1 Americas Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
- 5.1.2 Americas Therapeutic Nuclear Medicines Value by Countries (2014-2019)
- 5.2 Americas Therapeutic Nuclear Medicines Consumption by Type
- 5.3 Americas Therapeutic Nuclear Medicines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Therapeutic Nuclear Medicines Consumption by Countries
- 6.1.1 APAC Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
- 6.1.2 APAC Therapeutic Nuclear Medicines Value by Countries (2014-2019)
- 6.2 APAC Therapeutic Nuclear Medicines Consumption by Type
- 6.3 APAC Therapeutic Nuclear Medicines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Therapeutic Nuclear Medicines by Countries
- 7.1.1 Europe Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
- 7.1.2 Europe Therapeutic Nuclear Medicines Value by Countries (2014-2019)
- 7.2 Europe Therapeutic Nuclear Medicines Consumption by Type
- 7.3 Europe Therapeutic Nuclear Medicines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Therapeutic Nuclear Medicines by Countries
- 8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type
- 8.3 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Therapeutic Nuclear Medicines Distributors
- 10.3 Therapeutic Nuclear Medicines Customer
11 Global Therapeutic Nuclear Medicines Market Forecast
- 11.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2019-2024)
- 11.2 Global Therapeutic Nuclear Medicines Forecast by Regions
- 11.2.1 Global Therapeutic Nuclear Medicines Forecast by Regions (2019-2024)
- 11.2.2 Global Therapeutic Nuclear Medicines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Therapeutic Nuclear Medicines Forecast by Type
- 11.8 Global Therapeutic Nuclear Medicines Forecast by Application
12 Key Players Analysis
- 12.1 Bayer
- 12.1.1 Company Details
- 12.1.2 Therapeutic Nuclear Medicines Product Offered
- 12.1.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Bayer News
- 12.2 Novartis AG
- 12.2.1 Company Details
- 12.2.2 Therapeutic Nuclear Medicines Product Offered
- 12.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novartis AG News
- 12.3 China Isotope & Radiation
- 12.3.1 Company Details
- 12.3.2 Therapeutic Nuclear Medicines Product Offered
- 12.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 China Isotope & Radiation News
- 12.4 Dongcheng
- 12.4.1 Company Details
- 12.4.2 Therapeutic Nuclear Medicines Product Offered
- 12.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Dongcheng News
- 12.5 Q BioMed
- 12.5.1 Company Details
- 12.5.2 Therapeutic Nuclear Medicines Product Offered
- 12.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Q BioMed News
- 12.6 Curium Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Therapeutic Nuclear Medicines Product Offered
- 12.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Curium Pharmaceuticals News
- 12.7 Jubilant DraxImage
- 12.7.1 Company Details
- 12.7.2 Therapeutic Nuclear Medicines Product Offered
- 12.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Jubilant DraxImage News
- 12.8 Lantheus
- 12.8.1 Company Details
- 12.8.2 Therapeutic Nuclear Medicines Product Offered
- 12.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Lantheus News
- 12.9 Spectrum Pharmaceuticals
- 12.9.1 Company Details
- 12.9.2 Therapeutic Nuclear Medicines Product Offered
- 12.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Spectrum Pharmaceuticals News
- 12.10 Progenics Pharmaceuticals
- 12.10.1 Company Details
- 12.10.2 Therapeutic Nuclear Medicines Product Offered
- 12.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Progenics Pharmaceuticals News
- 12.11 International Isotopes
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Therapeutic Nuclear Medicines . Industry analysis & Market Report on Therapeutic Nuclear Medicines is a syndicated market report, published as Global Therapeutic Nuclear Medicines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Therapeutic Nuclear Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
